Last Updated : December 6, 2023
Details
FilesGeneric Name:
upadacitinib
Project Status:
Active
Therapeutic Area:
Crohns disease
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Rinvoq
Project Line:
Reimbursement Review
Project Number:
SR0775-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the treatment of adult patients with moderately to severely active Crohn's disease who have demonstrated prior treatment failure, i.e., an inadequate response to, loss of response to, or intolerance to at least one of conventional and/or biologic therapy.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of adult patients with moderately to severely active Crohn's disease who have demonstrated prior treatment failure, i.e., an inadequate response to, loss of response to, or intolerance to at least one of conventional and/or biologic therapy.
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
Call for patient/clinician input open | 16-Mar-23 |
---|---|
Call for patient/clinician input closed | 09-May-23 |
Clarification: - Patient input submission received from Crohn's and Colitis Canada and Gastrointestinal Society | |
Submission received | 05-Jun-23 |
Submission accepted | 19-Jun-23 |
Review initiated | 20-Jun-23 |
Draft CADTH review report(s) provided to sponsor for comment | 05-Sep-23 |
Deadline for sponsors comments | 14-Sep-23 |
CADTH review report(s) and responses to comments provided to sponsor | 13-Oct-23 |
Expert committee meeting (initial) | 25-Oct-23 |
Draft recommendation issued to sponsor | 06-Nov-23 |
Draft recommendation posted for stakeholder feedback | 16-Nov-23 |
End of feedback period | 30-Nov-23 |
Final recommendation issued to sponsor and drug plans | 14-Dec-23 |
Final recommendation posted | |
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | |
CADTH review report(s) posted |
Files
Last Updated : December 6, 2023